United States · Health Care · USD (Thousands) · Annual
Reported figures and Equlion model projections for the next 5 years.
Amounts in USD (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for Adagene Inc.? It covers the balance sheet, income statement, cash flow and Equlion model projections.
| Key metrics | Actual | Forecast | ||||
|---|---|---|---|---|---|---|
| Metric | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
| ROE | -55.21% | -1.59% | -1.74% | -1.98% | -2.18% | -2.4% |
|---|---|---|---|---|---|---|
| ROA | -32.61% | -0.89% | -0.96% | -1.07% | -1.14% | -1.22% |
| Gross Margin | 100% | 88.5% | 88.19% | 88.05% | 87.75% | 87.79% |
| Total Assets | $89,268.43K | $89,594.34K | $89,946.33K | $90,326.48K | $90,737.03K | $91,180.44K |
| Net Income | -$33,424.11K | -$796.14K | -$858.18K | -$960.17K | -$1,032.38K | -$1,109.83K |